Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vimpat as adjunctive therapy for partial-onset seizures in children (1 month to <4 years)
NCT02477839Phase 3Completed
- Sponsor
- UCB
- Start
- Jun 2015
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of lacosamide in epilepsy, sponsored by UCB. Started Jun 2015; status: completed.
02
Drugs
lacosamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02477839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477839.